ASCO: Little Help for Biotech Stocks
Two Big Winners in Bristol Myers Squibb and Celgene The American Society of Oncology Meeting is normally good times for biotech as scientific and clinical developments propel stocks. This year the personalized medicine theme with potential breakthroughs in targeted therapy for cancer is expected show excellent clinical results. In advance of ASCO Bristol Myers(BMY) presented [...]
